For Quick Alerts
ALLOW NOTIFICATIONS  
For Daily Alerts

Rossari Biotech Files For IPO Worth Rs 700 Crore With SEBI

By Staff
|

On Wednesday, Rossari Biotech Limited filed its draft papers with capital markets regulator SEBI (Securities and Exchange Board of India) to float a Rs 700 crore initial public offering (IPO). Rossario Biotech is a speciality chemical maker with a focus on home and personal care products.

Rossari Biotech Files For IPO Worth Rs 700 Crore With SEBI
 

The IPO will include fresh issuance of shares worth Rs 150 crore and sale of 1.05 crore equity shares by the company's promoters through the offer-for-sale (OFS) route, as per the company's draft prospectus filed with the SEBI.

New agency PTI's market sources have valued the IPO at Rs 700 crore.

The Mumbai-based company may consider a private pre-IPO placement of equity shares aggregating up to Rs 100 crore. If undertaken, the aggregated amount will be reduced from the fresh issue.

The company plans to utilise the net proceeds towards repayment or prepayment of certain indebtedness availed by Rossari Biotech, to fund working capital requirements and for general corporate purposes.

Read more about: ipo
Story first published: Thursday, December 19, 2019, 14:38 [IST]
Company Search
Get Instant News Updates
Enable
x
Notification Settings X
Time Settings
Done
Clear Notification X
Do you want to clear all the notifications from your inbox?
Settings X
We use cookies to ensure that we give you the best experience on our website. This includes cookies from third party social media websites and ad networks. Such third party cookies may track your use on Goodreturns sites for better rendering. Our partners use cookies to ensure we show you advertising that is relevant to you. If you continue without changing your settings, we'll assume that you are happy to receive all cookies on Goodreturns website. However, you can change your cookie settings at any time. Learn more